Working Knowledge
Business Research for Business Leaders
Filter Results: (190) Arrow Down

HealthRemove Health →

New research on the health industry from Harvard Business School faculty on issues including improving practice, health care technology, and public policy.
Page 1 of 190 Results →

Peloton Changed the Exercise Game. Can the Company Push Through the Pain?

by Lane Lambert

When COVID-19 closed gyms, seemingly everyone rushed to order a Peloton bike and claim a spot on the company's signature leader board. And then things quickly went downhill. A case study by Robert Dolan looks at the tough road the exercise equipment maker faces.

Lessons from COVID-19: The Business Skills Doctors Need

by Michael Blanding

The pandemic forced many physicians to become supply chain experts and strategic planners. Robert Huckman and colleagues offer a roadmap for teaching doctors the management and leadership skills they need—before the next public health crisis. Open for comment; 0 Comments.

Want to Prevent the Next Hospital Bed Crisis? Enlist the SEC

by Regina Herzlinger and Richard Boxer

After two years of COVID-19, many hospitals still haven't figured out how to manage the overwhelming wave of patients that flood ICUs during each surge. Regina Herzlinger and Richard Boxer offer a novel solution. Open for comment; 0 Comments.

Can Mass General Brigham Diversify Its Community of Innovators?

Re: Katherine B. Coffman

In November 2019, Mass General Brigham (MGB) was the largest recipient of National Institutes of Health funding in the world. The Innovation Office, led by Chief Innovation Officer Chris Coburn, sought to capitalize on that funding – with the goal of commercializing research done at the hospital to generate revenue and improve patient care. But CEO Anne Klibanski and other key stakeholders had a serious concern: although women comprised approximately 40 percent of the medical researchers and physicians at MGB, the percentage of women participating in innovation activities lagged behind. Associate Professor Katie Coffman, Coburn, and MGB’s managing director of administration and strategy Diana Schwartzstein discuss how they identify the main sources of the disparities and find the right strategy to expand and diversify MGB’s community of innovators in the case, “Inclusive Innovation at Mass General Brigham.” Open for comment; 0 Comments.

A Rare Find in Health Care: A Simple Solution to Racial Inequity

by Michael Blanding

Research by Amitabh Chandra offers a stark new explanation for racial disparities in heart attack survival rates—a problem with immediate answers. Open for comment; 0 Comments.

The High Cost of the Slow COVID Vaccine Rollout

by Michael Blanding

Aggressive investment in COVID-19 vaccine production earlier on could have saved lives and prevented $700 billion in global economic losses, says research by Scott Duke Kominers and colleagues. Open for comment; 0 Comments.

Kidney Exchange: An Operations Perspective

by Itai Ashlagi and Alvin E. Roth

Kidney exchange has become a standard form of transplantation in the United States and a few other countries in part because of exchange process improvements. However, much more needs to be done: There are still many more patients in need of transplants than can be saved.

How to Learn from the Big Mistake You Almost Make

by Kristen Senz

A brush with disaster can lead to important innovations, but only if employees have the psychological safety to reflect on these close calls, says research by Amy C. Edmondson, Olivia Jung, and colleagues. Open for comment; 0 Comments.

Hospital Allocation and Racial Disparities in Health Care

by Amitabh Chandra, Pragya Kakani, and Adam Sacarny

Black Americans experience disparities in health outcomes in the United States relative to other demographic groups. This study of heart attack sufferers over two decades develops a framework to examine the allocation of health care and the effectiveness of medical treatments, including beta-blockers and other technologies.

What Does December's Drug-Approval Dash Mean for COVID-19 Vaccines?

by Danielle Kost

Even in the best of times, pharmaceutical regulators tend to rush through drug applications in December. Now add in a ruthless pandemic. Research and insights from Lauren Cohen. Open for comment; 0 Comments.

Evaluating Innovative Health Care Solutions for Obesity

Re: Regina E. Herzlinger

From Weight Watchers to bariatric surgery, innovations for combatting obesity abound. But which will do the most good for society and yield the best business results? Professor Regina Herzlinger discusses a new case study. Open for comment; 0 Comments.

The COVID Gender Gap: Why Fewer Women Are Dying

by Dina Gerdeman

To promote the greatest safety, public health officials should target their pandemic messaging to men differently than to women. Research by Vincent Pons and colleagues. Open for comment; 0 Comments.

What Can Economics Say About Alzheimer's Disease?

by Amitabh Chandra, Courtney Coile, and Corina Mommaerts

This essay discusses the role of market frictions and "missing medicines" in drug innovation and highlights how frameworks and toolkits of economists can help our understanding of the determinants and effects of Alzheimer's disease on health.

Many Small-Business Employees May Be Close to Losing Health Insurance

by Rachel Layne

Small-business owners have delayed rent payments and other bills to protect health benefits for employees. Now, financial pressure is mounting, according to research by Leemore Dafny, Yin Wei Soon, Zoë Cullen, and Christopher Stanton. Open for comment; 0 Comments.

Why American Health Care Needs Its Own SEC

by Regina E. Herzlinger

The United States needs a health care equivalent of the Securities and Exchange Commission to increase transparency and competition, argues Regina Herzlinger. Open for comment; 0 Comments.

Can Shared Service Delivery Increase Customer Engagement? A Study of Shared Medical Appointments

by Ryan W. Buell, Kamalini Ramdas, and Nazlı Sönmez

Shared service delivery means that customers are served in groups rather than individually. Results from a large-scale study of glaucoma follow-up appointments at a major eye hospital indicate that shared service delivery can significantly improve patients’ verbal and non-verbal engagement.

Is a Pandemic the Best Time To Try Out a New Idea?

Re: Mitchell B. Weiss

Singapore's new nationwide, Bluetooth-based contact tracing program TraceTogether must overcome privacy issues to be effective. Would Singaporeans adopt TraceTogether? Professor Mitch Weiss discusses his new case study. Open for comment; 0 Comments.

COVID's Surprising Toll on Careers of Women Scientists

by Rachel Layne

Women scientists and those with young children are paying a steep career price in the pandemic, according to new research by Karim Lakhani, Kyle Myers, and colleagues. Open for comment; 0 Comments.

It's Time for a Bipartisan Health Plan for Employers and Employees

by Regina E. Herzlinger and Richard J. Boxer

Regina E. Herzlinger and Richard J. Boxer prescribe a seemingly impossible cure for battling health care options: a plan that embraces both Republican and Democratic ideas. Open for comment; 0 Comments.

Solving COVID'S Mental Health Crisis

by Howard Stevenson and Shirley Spence

COVID-19 affects more than physical health. Howard Stevenson and Shirley Spence describe how the pandemic is causing psychological trauma across a broad swath of society—and innovative methods to treat it. Open for comment; 0 Comments.